Patent · US Active

Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24

US7744894B2 · kind B2 · utility

3Cited by
8References
6Claims
0Family size

Inventors

Key dates

Filing dateMay 13, 2005
Grant dateJun 29, 2010
Priority date
Expiry dateNov 13, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for blocking autoreactive T cell-initiated destruction of tissues in a mammal are provided. In one embodiment, the methods involve administering an HAS/CD24 polypeptide or fragment thereof. In some embodiments, the polypeptide or fragment is glycosylated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.